American Portfolios Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

American Portfolios Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$432K	Sell	31,000 -35	-0.1%	-$564	0.02%	698
2022 Q2	$429K	Sell	31,035 -160	-0.5%	-$2.56K	0.02%	730
2022 Q1	$508K	Buy	31,195 +50	+0.2%	+$783	0.02%	724
2021 Q4	$507K	Hold	31,145	–	–	0.02%	730
2021 Q3	$463K	Sell	31,145 -50	-0.2%	-$800	0.02%	749
2021 Q2	$623K	Sell	31,195 -10	-0%	-$198	0.02%	618
2021 Q1	$720K	Buy	31,205 +21,000	+206%	+$585K	0.03%	520
2020 Q4	$252K	Sell	10,205 -1,100	-10%	-$36.5K	0.01%	805
2020 Q3	$469K	Sell	11,305 -75	-0.7%	-$3.45K	0.03%	509
2020 Q2	$545K	Buy	11,380 +275	+2%	+$21.2K	0.04%	417
2020 Q1	$699K	Sell	11,105 -798	-7%	-$71.7K	0.06%	286
2019 Q4	$1.48M	Buy	11,903 +748	+7%	+$67K	0.1%	199
2019 Q3	$740K	Hold	11,155	–	–	0.06%	305
2019 Q2	$888K	Buy	11,155 +11,050	+10,524%	+$989K	0.07%	258
2019 Q1	$11.7K	Hold	105	–	–	﹤0.01%	1765
2018 Q4	$10.6K	Sell	105 -60	-36%	-$6.22K	﹤0.01%	1593
2018 Q3	$20.8K	Sell	165 -1,855	-92%	-$196K	﹤0.01%	1471
2018 Q2	$169K	Buy	2,020 +1,475	+271%	+$108K	0.02%	613
2018 Q1	$33.5K	Sell	545 -40	-7%	-$2.41K	0.01%	1195
2017 Q4	$34.2K	Buy	+585	New	+$36.9K	0.01%	1137

Other funds holding ICPT

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Portfolios Advisors's ICPT Position: Q3 2022 in Review

American Portfolios Advisors reduced its Intercept Pharmaceuticals, Inc. (ICPT) stake by 0.11% in Q3 2022, selling an estimated $564 and leaving 31,000 shares worth $432K. The position accounts for 0.02% of the portfolio, ranked #698.

American Portfolios Advisors first reported a position in ICPT in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.48M in Q4 2019. 156 funds tracked by Wall St. Rank hold ICPT as of Q3 2022.

American Portfolios Advisors held 31,000 shares of Intercept Pharmaceuticals, Inc. worth $432K as of Q3 2022.
American Portfolios Advisors sold 35 Intercept Pharmaceuticals, Inc. shares in Q3 2022, an estimated $564.
Intercept Pharmaceuticals, Inc. made up 0.02% of American Portfolios Advisors's portfolio in Q3 2022, its #698 holding.
American Portfolios Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Intercept Pharmaceuticals, Inc. position peaked at $1.48M in Q4 2019.
156 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.